RI
CGON icon

RTW Investments’s CG Oncology CGON Stock Holding History

RTW Investments’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$473M Buy
6,984,808
+4,972,681
+247% +$282M 4.7% 6
2025
Q4 		$83.5M Buy
2,012,127
+310,911
+18% +$12.9M 0.84% 34
2025
Q3 		$68.5M Hold
1,701,216
– – 0.84% 33
2025
Q2 		$44.2M Hold
1,701,216
– – 0.63% 38
2025
Q1 		$41.7M Hold
1,701,216
– – 0.64% 33
2024
Q4 		$48.8M Buy
1,701,216
+357,142
+27% +$12.2M 0.74% 35
2024
Q3 		$50.7M Hold
1,344,074
– – 0.73% 33
2024
Q2 		$42.4M Buy
1,344,074
+930,404
+225% +$32.2M 0.66% 36
2024
Q1 		$18.2M Buy
+413,670
New +$16.9M 0.27% 50

Other funds holding CGON

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments's CGON Position: Q1 2026 in Review

RTW Investments increased its CG Oncology (CGON) stake by 247% in Q1 2026, buying an estimated $282M and bringing the position to 6,984,808 shares worth $473M. The position accounts for 4.7% of the portfolio, ranked #6.

RTW Investments first reported a position in CGON in Q1 2024 and has held it in 9 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • RTW Investments held 6,984,808 shares of CG Oncology worth $473M as of Q1 2026.
  • RTW Investments bought 4,972,681 CG Oncology shares in Q1 2026, an estimated $282M.
  • CG Oncology made up 4.7% of RTW Investments's portfolio in Q1 2026, its #6 holding.
  • RTW Investments first reported a position in CG Oncology in Q1 2024 and has held it in 9 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on RTW Investments's 13F filing for Q1 2026, filed 15 May 2026.